ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,444.00
2.16%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,934.22
6.45%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) 뉴스

SPRC SciSparc Ltd

1.26
0.00 (0.00%)
시간외 거래
최종 업데이트: 06:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
SciSparc Ltd SPRC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 1.26 06:00:00
개장가 저가 고가 종가 전일 종가
1.32 1.24 1.3351 1.26 1.26
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/04/202421:15GLOBESciSparc to Acquire AutoMax
21/03/202421:58GLOBESciSparc: MitoCareX Unveils Groundbreaking Discovery of..
18/03/202420:29GLOBESciSparc Granted Another Patent, Strengthening its Core..
14/03/202421:49GLOBESciSparc Achieves Major Milestone with First Patient Dosed..
12/03/202421:14GLOBESciSparc: MitoCareX Reveals Promising Results with Discovery..
08/03/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/03/202421:11GLOBESciSparc Announces Enrollment of First Patient for its..
07/03/202421:49GLOBESciSparc Granted Patent for Core Technology in Multiple..
07/03/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
07/03/202406:41GLOBESciSparc Issued Canadian Patent for Opioids Reduction Use in..
29/02/202423:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/02/202422:35GLOBESciSparc Delivers Treatment for Autism Spectrum Disorder..
28/02/202406:15EDGAR2Form F-1 - Registration statement for certain foreign..
27/02/202422:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/02/202421:58GLOBEClearmind Medicine Submits Three Additional International..
21/02/202406:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/02/202421:14GLOBEClearmind Medicine Submits Three International Patent..
13/02/202406:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/01/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/01/202421:18GLOBESciSparc Announces Initiation of Patient Recruitment for its..
25/01/202423:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/01/202421:42GLOBESciSparc Ltd. Announces $20 Million Standby Equity Purchase..
22/01/202420:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/01/202423:28GLOBESciSparc Advances the Acquisition Process of a Leading..
04/01/202421:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
13/12/202322:18GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
08/12/202322:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/12/202323:05GLOBESciSparc Provides Updates Regarding the Non-Binding Letter..
01/12/202322:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
29/11/202306:55EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
29/11/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
28/11/202322:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
28/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202322:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
24/11/202322:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
23/11/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202321:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
21/11/202306:22EDGAR2Form F-3/A - Registration statement by foreign private..
15/11/202322:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
10/11/202323:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
04/11/202305:06EDGAR2Form F-3 - Registration statement by foreign private issuers
31/10/202321:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202320:38GLOBESciSparc Granted Patent from the Australian Patent Office..
24/10/202320:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202320:20GLOBESciSparc Granted Patent for its Core Technology From the..
18/10/202319:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

NASDAQ
SPRC
SciSparc
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유